Trials / Completed
CompletedNCT06198556
Effect of Rifampicin on the Pharmacokinetics of HRS-1167 in Healthy Subjects
A Single Center, Single Arm, Open, Fixed Sequence Study on the Pharmacokinetic Effects of Rifampicin on Oral Administration of HRS-1167 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of the study is to evaluate the effect of rifampicin on pharmacokinetics of healthy adult subjects after oral administration of HRS-1167 tablets. The secondary objective of the study is to evaluate the safety of HRS-1167 alone and when co-administered with rifampicin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-1167 tablets; rifampicin | HRS-1167 tablets single oral dose of HRS-1167 or co-administered with rifampicin. |
Timeline
- Start date
- 2024-01-14
- Primary completion
- 2024-02-05
- Completion
- 2024-02-05
- First posted
- 2024-01-10
- Last updated
- 2024-02-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06198556. Inclusion in this directory is not an endorsement.